当前位置：
X-MOL 学术
›
Eur. Urol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
European Urology ( IF 25.3 ) Pub Date : 2024-05-13 , DOI: 10.1016/j.eururo.2024.05.001 Martina Catalano 1 , Matteo Santoni 2 , Giandomenico Roviello 1
中文翻译：
回复：Enfortumab Vedotin 和 Pembrolizumab 治疗未经治疗的晚期尿路上皮癌
更新日期：2024-05-13
European Urology ( IF 25.3 ) Pub Date : 2024-05-13 , DOI: 10.1016/j.eururo.2024.05.001 Martina Catalano 1 , Matteo Santoni 2 , Giandomenico Roviello 1
Affiliation
中文翻译：
回复：Enfortumab Vedotin 和 Pembrolizumab 治疗未经治疗的晚期尿路上皮癌
京公网安备 11010802027423号